Parry Nutraceuticals will focus on the business of natural products for human wellness through Health Supplements and Functional Foods by offering high quality products backed by science, addressing the global market.
Parry Nutraceuticals is a division of EID Parry (I) Ltd. and part of the USD 4.4 Billion Murugappa Group.
Headquartered in Chennai, India, E.I.D. Parry has been synonymous with dynamism since 1788. It became a part of the Murugappa Group in 1981 and its businesses now cover a wide range of products including sugar, microalgal health supplements from Parry Nutraceuticals and bio products from Bio Products Division.
The Murugappa Group is one of India's leading business conglomerates; the market leaders in diverse areas of business, including Engineering, Abrasives, Finance, General Insurance, Cycles, Sugar, Farm Inputs, Fertilizers, Plantations, Bio-products and Nutraceuticals. Its 28 businesses have manufacturing facilities spread across 13 states in India. The organization fosters an environment of professionalism and has a workforce of over 32,000 employees. The Group has forged strong joint venture alliances with leading international companies like Mitsui Sumitomo, Foskor, Cargill and Groupe Chimique Tunisien, thus consolidating its status as one of the fastest growing diversified business houses in India.
A nutraceutical is a portmanteau of the words “nutrition” and “pharmaceutical”; it is a food or food product that provides health and medical benefits, including the prevention and treatment of disease.
Parry Nutraceuticals are pioneers in nutritional supplements, focusing on good health by harnessing the richness of nature backed by technology in cultivation, extraction, formulation and branding. It has emerged as a global leader in micro-algal technology, producing the world’s finest Certified Organic Spirulina, natural beta Carotene and Astaxanthin, among other products catering to Nutraceutical markets in 38 countries across the world, including the main markets like US, Europe and Asia.
Today, Parry Nutraceuticals is consolidating its presence in the “Over the Counter” (OTC) segment, which is driven by a panel of experts, including senior medical professionals, scientists, nutritionists, and a management team, all of whom share a common vision of focusing on the business of natural products for human wellness through health supplements and high quality functional foods, and developing and commercializing science-based clinically proven formulations based on intensive research supported by a robust understanding of consumer trends and the expectations of the global market.
Parry Nutraceuticals partners with Valensa International, USA, an organization dedicated to the use of superior science to deliver ingredients that can meet the burgeoning consumer demand for efficacious, high quality natural botanical extracts.